Skip to main content
logo
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
11.08
-0.38 (-3.32%)
At close: Sep 4, 2026, 4:00 PM EDT
10.99
-0.09 (-0.81%)
After-hours: Sep 4, 2026, 7:30 PM EDT

CRBP Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-101.9-78.54-40.21-44.6-42.35-45.64
Depreciation & Amortization
0.20.230.590.640.761.64
Other Amortization
--0.40.820.740.7
Loss (Gain) From Sale of Assets
----0.020.1
Asset Writedown & Restructuring Costs
-----0.61
Loss (Gain) From Sale of Investments
-1.31-1.37-3.33-0.510.30.7
Stock-Based Compensation
6.736.296.153.475.729.73
Other Operating Activities
0.15-0.230.19-0.020.55-0.32
Change in Accounts Receivable
-----1.62
Change in Accounts Payable
1.1-2.351.61.03-0.26-5.96
Change in Other Net Operating Assets
8.3611.47-7.183.07-3.04-11.36
Operating Cash Flow
-86.67-64.49-41.79-36.1-37.54-48.18
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.02-0.01---0.01-0.05
Sale of Property, Plant & Equipment
----0.010.02
Investment in Securities
3.23-1.63-121.3135.6430.08-73.39
Investing Cash Flow
3.21-1.64-121.3135.6430.07-73.42

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---0.370.450.98
Long-Term Debt Issued
----1.38-
Total Debt Issued
---0.371.830.98
Short-Term Debt Repaid
---0.3-0.43-0.87-0.93
Long-Term Debt Repaid
---15.18-2.82-1.5-
Total Debt Repaid
---15.48-3.25-2.37-0.93
Net Debt Issued (Repaid)
---15.48-2.87-0.530.06
Issuance of Common Stock
86.577.43182.060.05-62.59
Other Financing Activities
------1.82
Financing Cash Flow
86.577.43166.58-2.82-0.5360.82

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
3.0411.293.47-3.28-8-60.78

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-86.69-64.5-41.79-36.1-37.56-48.24
Free Cash Flow Growth
------
Free Cash Flow Margin
------5470.98%
Free Cash Flow Per Share
-5.18-4.84-3.83-8.34-9.01-11.78
Levered Free Cash Flow
-49.62-37.73-29.8-21.27-18.72-39.01
Unlevered Free Cash Flow
-49.62-37.73-29.03-19.68-17.53-38.02

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--2.822.611.971.74
Change in Working Capital
9.469.12-5.584.09-3.3-15.7
SEC Filings: 10-K · 10-Q